Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 235

1.

Predictors of Care Gaps in Home Dialysis: The Home Dialysis Virtual Ward Study.

Nadeau-Fredette AC, Chan CT, Bargman JM, Copland MA, Finkle SN, Oliver MJ, Pauly RP, Perl J, Shah NA, Zimmerman DL, Tennankore KK.

Am J Nephrol. 2019 Oct 10:1-9. doi: 10.1159/000503439. [Epub ahead of print]

PMID:
31600760
2.

Characteristics Associated With Peritoneal Dialysis Technique Failure: Are We Asking the Right Questions?

Nadeau-Fredette AC, Bargman JM.

Am J Kidney Dis. 2019 Sep 9. pii: S0272-6386(19)30884-4. doi: 10.1053/j.ajkd.2019.07.002. [Epub ahead of print] No abstract available.

PMID:
31515139
3.

Defining the role of peritoneal dialysis in management of congestive heart failure.

Kazory A, Bargman JM.

Expert Rev Cardiovasc Ther. 2019 Jul;17(7):533-543. doi: 10.1080/14779072.2019.1637254. Epub 2019 Jul 2. Review.

PMID:
31242777
4.

Use of vitamin D drops leading to kidney failure in a 54-year-old man.

Auguste BL, Avila-Casado C, Bargman JM.

CMAJ. 2019 Apr 8;191(14):E390-E394. doi: 10.1503/cmaj.180465. No abstract available.

PMID:
30962197
5.

Supporting the Establishment of New Home Dialysis Programs Through the Explore Home Dialysis Program.

Morita PP, Huynh K, Zakir A, Cafazzo JA, McQuillan RF, Bargman JM, Chan CTM.

Kidney Int Rep. 2018 Oct 29;4(2):293-300. doi: 10.1016/j.ekir.2018.10.019. eCollection 2019 Feb.

6.

Incremental peritoneal dialysis: New ideas about an old approach.

Auguste BL, Bargman JM.

Semin Dial. 2018 Sep;31(5):445-448. doi: 10.1111/sdi.12712. Epub 2018 May 28.

PMID:
29806970
7.

Antimalarial Drugs for the Prevention of Chronic Kidney Disease in Patients with Rheumatoid Arthritis: The Importance of Controlling Chronic Inflammation?

Rodrigues JC, Bargman JM.

Clin J Am Soc Nephrol. 2018 May 7;13(5):679-680. doi: 10.2215/CJN.03300318. Epub 2018 Apr 16. No abstract available.

8.

Should we look beyond Kt/V urea in assessing dialysis adequacy?

Jones CB, Bargman JM.

Semin Dial. 2018 Jul;31(4):420-429. doi: 10.1111/sdi.12684. Epub 2018 Mar 23. Review.

PMID:
29573025
9.

Visions in a Crystal Ball: The Future of Peritoneal Dialysis.

Bargman JM, Girsberger M.

Blood Purif. 2018;45(1-3):218-223. doi: 10.1159/000485158. Epub 2018 Jan 26. Review.

10.

Increased Serum Lactate in Peritoneal Dialysis Patients Presenting with Intercurrent Illness.

Trinh E, Saiprasertkit N, Bargman JM.

Perit Dial Int. 2018 Sep-Oct;38(5):363-365. doi: 10.3747/pdi.2017.00169. Epub 2018 Jan 31.

PMID:
29386309
11.

Peritoneal Dialysis in Orthotopic Liver Transplantation Recipients.

Saiprasertkit N, Nihei CH, Bargman JM.

Perit Dial Int. 2018 Jan-Feb;38(1):44-48. doi: 10.3747/pdi.2017.00134. Epub 2017 Nov 21.

PMID:
29162680
12.

Klebsiella pneumoniae Renal Abscess and Peritonitis in a Peritoneal Dialysis Patient: A Novel Route of Infection.

Dhruve MJ, Bargman JM.

Perit Dial Int. 2017 Nov-Dec;37(6):654-656. doi: 10.3747/pdi.2017.00094.

PMID:
29123004
13.

Residual Kidney Function and Peritoneal Dialysis-Associated Peritonitis Treatment Outcomes.

Whitty R, Bargman JM, Kiss A, Dresser L, Lui P.

Clin J Am Soc Nephrol. 2017 Dec 7;12(12):2016-2022. doi: 10.2215/CJN.00630117. Epub 2017 Nov 7.

14.

Can we manage lupus nephritis without chronic corticosteroids administration?

Lightstone L, Doria A, Wilson H, Ward FL, Larosa M, Bargman JM.

Autoimmun Rev. 2018 Jan;17(1):4-10. doi: 10.1016/j.autrev.2017.11.002. Epub 2017 Nov 3. Review.

15.

Treatment of asymptomatic hyperuricemia in chronic kidney disease: A new target in an old enemy - A review.

Ramirez MEG, Bargman JM.

J Adv Res. 2017 Sep;8(5):551-554. doi: 10.1016/j.jare.2017.04.006. Epub 2017 May 2. Review.

16.

The Interaction of Dialysis Prescription and Residual Kidney Function: Yet Another Layer of Complexity.

Bargman JM, Jones CB.

Am J Kidney Dis. 2017 Apr;69(4):489-491. doi: 10.1053/j.ajkd.2017.01.001. No abstract available.

PMID:
28340849
17.

The Use of a Multidimensional Measure of Dialysis Adequacy-Moving beyond Small Solute Kinetics.

Perl J, Dember LM, Bargman JM, Browne T, Charytan DM, Flythe JE, Hickson LJ, Hung AM, Jadoul M, Lee TC, Meyer KB, Moradi H, Shafi T, Teitelbaum I, Wong LP, Chan CT; American Society of Nephrology Dialysis Advisory Group.

Clin J Am Soc Nephrol. 2017 May 8;12(5):839-847. doi: 10.2215/CJN.08460816. Epub 2017 Mar 17. Review.

18.

Ethical issues in dialysis therapy.

Jha V, Martin DE, Bargman JM, Davies S, Feehally J, Finkelstein F, Harris D, Misra M, Remuzzi G, Levin A; International Society of Nephrology Ethical Dialysis Task Force.

Lancet. 2017 May 6;389(10081):1851-1856. doi: 10.1016/S0140-6736(16)32408-4. Epub 2017 Feb 24.

PMID:
28238456
19.

Dialysis Modality and Readmission Following Hospital Discharge: A Population-Based Cohort Study.

Perl J, McArthur E, Bell C, Garg AX, Bargman JM, Chan CT, Harel S, Li L, Jain AK, Nash DM, Harel Z.

Am J Kidney Dis. 2017 Jul;70(1):11-20. doi: 10.1053/j.ajkd.2016.10.020. Epub 2017 Jan 6.

PMID:
28069285
20.

Antibiotic Prophylaxis in Peritoneal Dialysis Patients.

Dhruve MJ, Bargman JM.

Adv Perit Dial. 2017 Jan;33(2017):55-58.

PMID:
29668433
21.

Renal Tubular Toxicity Associated With Rosuvastatin Therapy.

Ward FL, John R, Bargman JM, McQuillan RF.

Am J Kidney Dis. 2017 Mar;69(3):473-476. doi: 10.1053/j.ajkd.2016.08.037. Epub 2016 Nov 14.

PMID:
27856086
22.

Myths in peritoneal dialysis.

Lee MB, Bargman JM.

Curr Opin Nephrol Hypertens. 2016 Nov;25(6):602-608. Review.

PMID:
27584930
23.

Membranous Lupus Nephritis: The Same, But Different.

Ward F, Bargman JM.

Am J Kidney Dis. 2016 Dec;68(6):954-966. doi: 10.1053/j.ajkd.2016.07.026. Epub 2016 Sep 20. Review.

PMID:
27663040
24.

The Enigmatic Fallopian Tube: A More Common Cause of Catheter Malfunction than Previously Recognized.

Gudsoorkar PS, Penner T, Jassal SV, Bargman JM.

Perit Dial Int. 2016 Jul-Aug;36(4):459-61. doi: 10.3747/pdi.2015.00125.

25.

We Use Kt/V Urea as a Measure of Adequacy of Peritoneal Dialysis.

Bargman JM.

Semin Dial. 2016 Jul;29(4):258-9. doi: 10.1111/sdi.12504. Epub 2016 Apr 15.

PMID:
27081745
26.

Are Diuretics Underutilized in Dialysis Patients?

Trinh E, Bargman JM.

Semin Dial. 2016 Sep;29(5):338-41. doi: 10.1111/sdi.12483. Epub 2016 Apr 8.

PMID:
27060970
27.

Rate of Decline of Residual Kidney Function Before and After the Start of Peritoneal Dialysis.

He L, Liu X, Li Z, Abreu Z, Malavade T, Lok CE, Bargman JM.

Perit Dial Int. 2016 May-Jun;36(3):334-9. doi: 10.3747/pdi.2016.00024. Epub 2016 Apr 4.

28.

Peritoneal dialysis: from bench to bedside and bedside to bench.

Perl J, Bargman JM.

Am J Physiol Renal Physiol. 2016 Nov 1;311(5):F999-F1004. doi: 10.1152/ajprenal.00012.2016. Epub 2016 Mar 23.

29.

Survival by Dialysis Modality-Who Cares?

Lee MB, Bargman JM.

Clin J Am Soc Nephrol. 2016 Jun 6;11(6):1083-7. doi: 10.2215/CJN.13261215. Epub 2016 Feb 11.

30.
31.

Survival Comparisons in Home Dialysis: Where You Finish Depends on Where You Start.

Misra PS, Bargman JM, Perl J.

Am J Kidney Dis. 2016 Jan;67(1):13-5. doi: 10.1053/j.ajkd.2015.10.001. No abstract available.

PMID:
26708194
32.

Managing Older Patients on Peritoneal Dialysis.

Brown EA, Bargman JM, Li PK.

Perit Dial Int. 2015 Nov;35(6):609-11. doi: 10.3747/pdi.2015.00159. No abstract available.

33.

Analysis of Hospitalization after Peritoneal Dialysis Catheter Implantation.

Li Z, Abreu Z, Penner T, He L, Liu X, Bargman JM.

Perit Dial Int. 2016 9-10;36(5):540-6. doi: 10.3747/pdi.2014.00333. Epub 2015 Oct 16.

34.

Peritoneal Dialysis for Chronic Congestive Heart Failure.

François K, Ronco C, Bargman JM.

Blood Purif. 2015;40(1):45-52. doi: 10.1159/000430084. Epub 2015 Jun 24. Review.

35.

An education initiative modifies opinions of hemodialysis nurses towards home dialysis.

Phillips M, Wile C, Bartol C, Stockman C, Dhir M, Soroka SD, Hingwala J, Bargman JM, Chan CT, Tennankore KK.

Can J Kidney Health Dis. 2015 Apr 28;2:16. doi: 10.1186/s40697-015-0051-z. eCollection 2015.

36.

The Benefit of a Glucose-Sparing PD Therapy on Glycemic Control Measured by Serum Fructosamine in Diabetic Patients in a Randomized, Controlled Trial (IMPENDIA).

Li PK, Dorval M, Johnson DW, Rutherford P, Shutov E, Story K, Bargman JM.

Nephron. 2015;129(4):233-40. doi: 10.1159/000371554. Epub 2015 Mar 4.

37.

Timing of Initiation of RRT and Modality Selection.

Bargman JM.

Clin J Am Soc Nephrol. 2015 Jun 5;10(6):1072-7. doi: 10.2215/CJN.12621214. Epub 2015 Mar 11.

38.

Asymptomatic peritoneal leukocytosis after exteriorization of buried peritoneal dialysis catheters: a case series.

Dahlan R, Bargman JM, Biyani M, Lavoie S, McCormick BB.

Perit Dial Int. 2015 Jan-Feb;35(1):103-5. doi: 10.3747/pdi.2013.00196. No abstract available.

39.

Evaluating the benefits of home-based peritoneal dialysis.

François K, Bargman JM.

Int J Nephrol Renovasc Dis. 2014 Dec 4;7:447-55. doi: 10.2147/IJNRD.S50527. eCollection 2014. Review.

40.

A review of diuretic use in dialysis patients.

Kumra R, Bargman JM.

Adv Perit Dial. 2014;30:115-9. Review.

PMID:
25338432
41.

Gastroscopy-related peritonitis in peritoneal dialysis patients.

Nadeau-Fredette AC, Bargman JM.

Perit Dial Int. 2014 Sep-Oct;34(6):667-70. doi: 10.3747/pdi.2012.00340. No abstract available.

42.

Asymptomatic hyponatremia in peritoneal dialysis patients: an algorithmic approach.

Musso CG, Bargman JM.

Int Urol Nephrol. 2014 Nov;46(11):2239-41. doi: 10.1007/s11255-014-0817-8. Epub 2014 Aug 22. No abstract available.

PMID:
25145783
43.

Influence of low-glucose peritoneal dialysis on serum lipids and apolipoproteins in the IMPENDIA/EDEN trials.

Sniderman AD, Sloand JA, Li PK, Story K, Bargman JM.

J Clin Lipidol. 2014 Jul-Aug;8(4):441-7. doi: 10.1016/j.jacl.2014.03.007. Epub 2014 Apr 13.

44.

Successful peritoneal dialysis in 2 siblings with Alport's disease and gastric pull-up.

Vellanki VS, Bargman JM.

Perit Dial Int. 2014 Jul-Aug;34(5):565-6. doi: 10.3747/pdi.2013.00127. No abstract available.

45.

Twice-weekly and incremental hemodialysis treatment for initiation of kidney replacement therapy.

Kalantar-Zadeh K, Unruh M, Zager PG, Kovesdy CP, Bargman JM, Chen J, Sankarasubbaiyan S, Shah G, Golper T, Sherman RA, Goldfarb DS.

Am J Kidney Dis. 2014 Aug;64(2):181-6. doi: 10.1053/j.ajkd.2014.04.019. Epub 2014 May 17. Review.

46.

Resolution of proteinuria in lupus nephritis: hurry up and wait.

Bargman JM, Avila-Casado C.

J Rheumatol. 2014 Apr;41(4):622-5. doi: 10.3899/jrheum.140157. No abstract available.

PMID:
24692601
47.

Peritonitis caused by veillonella species and Eggerthella lenta in peritoneal dialysis.

Goupil R, Nadeau-Fredette AC, Tennankore KK, Bargman JM.

Perit Dial Int. 2014 Mar-Apr;34(2):245-7. doi: 10.3747/pdi.2013.00046. No abstract available.

48.

Clinical outcome of home hemodialysis in patients with previous peritoneal dialysis exposure: evaluation of the integrated home dialysis model.

Nadeau-Fredette AC, Bargman JM, Chan CT.

Perit Dial Int. 2015 May-Jun;35(3):316-23. doi: 10.3747/pdi.2013.00163. Epub 2014 Mar 1.

49.

Rationale for a home dialysis virtual ward: design and implementation.

Schachter ME, Bargman JM, Copland M, Hladunewich M, Tennankore KK, Levin A, Oliver M, Pauly RP, Perl J, Zimmerman D, Chan CT.

BMC Nephrol. 2014 Feb 14;15:33. doi: 10.1186/1471-2369-15-33.

50.

Aspergillus Niger peritonitis in a peritoneal dialysis patient treated with eculizumab.

Vellanki VS, Bargman JM.

Ren Fail. 2014 May;36(4):631-3. doi: 10.3109/0886022X.2014.882712. Epub 2014 Feb 10.

PMID:
24512095

Supplemental Content

Loading ...
Support Center